Background
Beginning in 2009, New Jersey hired several major financial institutions — including JPMorgan Chase, Citigroup, Bank of America, Wells Fargo, and Morgan Stanley — as remarketing agents (RMAs) for Variable Rate Demand Obligations (VRDOs), tax-exempt bonds the State uses to finance long-term projects at short-term interest rates. The agreements required each RMA to price bonds individually, based on each bond’s characteristics and market conditions. B. Johan Rosenberg, a municipal advisor and sole principal of Edelweiss Fund, LLC, suspected the banks were instead “robo-resetting” rates — automatically resetting VRDO interest rates en masse at artificially high levels, ensuring bonds stayed with investors and shielding the banks from their letter-of-credit obligations. In 2015, Edelweiss filed a qui tam complaint under seal on behalf of New Jersey under the New Jersey False Claims Act (NJFCA), alleging the banks defrauded the State. The Attorney General declined to intervene.
Defendants moved to dismiss based on the NJFCA’s public disclosure bar, which prohibits qui tam suits premised on publicly available information unless the relator is an original source. The trial court initially granted dismissal, finding the underlying VRDO rate data was publicly accessible through sources such as the MSRB’s EMMA portal and Bloomberg terminals. After Edelweiss filed a fourth amended complaint in 2021, the trial court denied a second motion to dismiss and ordered discovery limited to the public disclosure bar question. Cross-motions for summary judgment followed.
While those motions were pending, the New Jersey Legislature enacted amendments to the NJFCA in June 2023, including the “Opposition Amendment” to N.J.S.A. 2A:32C-9(c). The prior statute allowed the Attorney General to neutralize the public disclosure bar only by formally intervening and taking over the litigation. The amendment created a new, streamlined mechanism: the Attorney General could now simply file a notice of opposition, without intervening, to block application of the bar. The Legislature directed that the amendments “take effect immediately.” In August 2023, the Attorney General filed a notice of opposition in the Edelweiss matter. The trial court granted summary judgment for Edelweiss, holding the Opposition Amendment applied. The Appellate Division reversed, ruling the amendment did not apply retroactively to this pre-existing case. The Supreme Court granted certification.
The Court’s Holding
Writing for a unanimous Court, Justice Pierre-Louis reversed the Appellate Division. The Court held that the Opposition Amendment is procedural — not substantive — in nature and therefore applies to all pending cases upon its effective date, consistent with the Legislature’s directive that it “take effect immediately.” Under long-standing New Jersey law, codified in N.J.S.A. 1:1-14, procedural amendments govern pending proceedings; only substantive amendments — those affecting pre-litigation rights and liabilities — are presumed to operate prospectively. The Attorney General’s August 2023 notice of opposition was therefore effective, and the case may proceed.
The Court grounded its analysis in the substance-versus-procedure distinction articulated in New Jersey precedent and reinforced by the U.S. Supreme Court in Landgraf v. USI Film Products, 511 U.S. 244 (1994). A law does not operate “retroactively” simply because it is applied to a case involving pre-enactment conduct; what matters is whether it attaches new legal consequences to completed events, increases past liability, or impairs rights that vested when the parties acted. The Opposition Amendment does none of these things. It regulates litigation conduct — specifically, the mechanism by which the Attorney General may exercise a power it always possessed — and thus falls on the procedural side of the line.
The Court distinguished State ex rel. Health Choice Group, LLC v. Bayer Corp., 478 N.J. Super. 184 (App. Div. 2024), in which the Appellate Division held that a separate 2023 amendment to the NJFCA’s “original source” language did not apply to pending cases. The original-source amendment altered the substantive elements needed to qualify as an exception to the public disclosure bar — a change touching the merits of a party’s rights. The Opposition Amendment, by contrast, only changed how the Attorney General could activate an already-existing power to override the bar. Because defendants always faced the risk that the Attorney General would intervene and defeat the public disclosure defense, they had no vested right to rely on that defense free from the Attorney General’s opposition.
Key Takeaways
- The 2023 NJFCA Opposition Amendment, which allows the Attorney General to block the public disclosure bar by filing a notice of opposition rather than formally intervening, is a procedural change that applies to all pending qui tam actions as of its June 2023 effective date.
- Courts must evaluate NJFCA amendments individually: the “original source” amendment addressed in Health Choice was substantive and prospective-only, while the Opposition Amendment is procedural and immediately applicable — the two do not stand or fall together.
- Defendants in qui tam actions cannot claim a vested right in the public disclosure bar when the Attorney General always had the authority to defeat that defense through intervention; the amendment merely streamlined the exercise of that existing authority.
- Under N.J.S.A. 1:1-14 and the Landgraf framework, a procedural amendment’s “take effect immediately” language means what it says for pending cases — it does not signal prospective-only application the way it would for a substantive change.
Why It Matters
This decision significantly expands the practical reach of New Jersey’s False Claims Act in active litigation. Qui tam relators in pending cases — including fraud suits against financial institutions, healthcare providers, and government contractors — can now benefit from the Attorney General’s opposition to the public disclosure bar even if the AG previously declined to intervene. The ruling removes what had been a potentially dispositive procedural hurdle for relators whose underlying information touches publicly available data, so long as the State signals the lawsuit is not “parasitic.”
For defense counsel, the ruling closes an avenue that had seemed promising after the Appellate Division’s reversal. Major financial institutions facing similar VRDO-rate claims in other jurisdictions — proceedings are reportedly pending in New York — will watch whether parallel state statutes receive analogous treatment. More broadly, the Court’s careful line between the substantive “original source” amendment and the procedural “opposition” mechanism offers a template for how legislatures can expand enforcement tools for pending cases without triggering retroactivity concerns, provided the change goes to litigation mechanics rather than primary conduct.